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Taipei and Douliou, TaiwanOBJECTIVES This study evaluated whether the conductive channel (CC) identiﬁed by late gadolin-
ium enhanced–cardiac magnetic resonance (LGE-CMR) is associated with ventricular tachycardia (VT) in
patients with systolic heart failure (HF).
BACKGROUND One recent study demonstrated that the CC formed by heterogeneous tissue within
the core scar could be detected by LGE-CMR and that the CC is responsible for clinical VT. We hypoth-
esized that the CC could help identify HF patients at risk for VT.
METHODS A total of 63 patients from a CMR database with left ventricular ejection fraction (LVEF)
below 50% and with hyperenhancement on LGE-CMR were included. The cine and LGE images were
analyzed to derive the LV function and scar characteristics, and to identify the CC. The outcomes,
including VT, ventricular ﬁbrillation (VF), and total mortality, were obtained by reviewing medical
records.
RESULTS After a median 1,379 (interquartile range: 271 to 1,896) days of follow-up, 8 patients had
VT/VF attacks and 14 patients died. Among the CMR-measured parameters, only the probability of
identifying the CC by LGE-CMR was higher in patients with VT/VF than those without VT/VF
(75.0% vs. 16.4%, p < 0.001). The probability of identifying the CC was also higher in the total mor-
tality group than the survival group (50.0% vs. 16.3%, p ¼ 0.004). The other LGE-CMR variables were
not signiﬁcantly different between the 2 groups. A univariate Cox regression model showed that CC
identiﬁcation was positively associated with VT/VF attacks (hazard ratio [HR]: 27.032, 95% conﬁdence
interval [CI]: 3.291 to 222.054, p ¼ 0.002) and excess total mortality (HR: 4.766, 95% CI: 1.643 to
13.824, p ¼ 0.004). The LVEF was inversely associated with VT/VF attacks (HR: 0.119, 95% CI: 0.015
to 0.977, p ¼ 0.048) and excess total mortality (HR: 0.491, 95% CI: 0.261 to 0.925, p ¼ 0.028) during
follow-up.
CONCLUSIONS We demonstrated that CC identiﬁcation using LGE-CMR can help identify HF patients
at risk for VT/VF. (J Am Coll Cardiol Img 2013;6:1152–9) ª 2013 by the American College of Cardiology
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1153atients with congestive heart failure (HF)
carry an additional risk of morbidity andA B B R E V I A T I O N S
A N D A C R O N YM S
CC = conductive channel
CMR = cardiac magnetic
resonance
EAVM = electroanatomical
voltage mapping
HF = heart failure
LGE-CMR = late gadolinium
enhanced–cardiac magnetic
resonance
LV = left ventricle/ventricular
LVEF = left ventricular ejection
fraction
MI = myocardial infarction
PSIR = phase-sensitive inversion
recovery
SI = signal intensity
VF = ventricular ﬁbrillation
entricular tachycardiamortality (1). It is of clinical importance to
identify these high-risk patients because
optimal medical and device therapy could substan-
tially lower this risk (2,3). Recently, late gadolinium
enhanced–cardiac magnetic resonance (LGE-CMR)
has become a powerful tool for predicting cardiac
events (4–6). In contrast to the precise left ventricular
(LV) systolic function measurement offered by cine
cardiac magnetic resonance (CMR), LGE-CMR has
excellent sensitivity and speciﬁcity for detecting small
myocardial scars and quantifying the core scar and
border zone (5,6).
More recently, researchers have found that LGE-
CMR could help identify the abnormal substrate
for ventricular tachycardia, which could therefore
facilitate the ablation procedure (7,8). Through
image integration, LGE-CMR has been shown to
detect ventricular tachycardia (VT)-associated scars
that could not be identiﬁed by invasive electro-
anatomical voltage mapping (EAVM) (7). In 1
study, Perez-David et al. (8) showed that with
computer-assisted visual identiﬁcation, LGE-CMR
could help detect the conductive channel (CC)
within the scars. Through concomitant EAVM and
electrophysiology analysis, the researchers further
demonstrated that a signiﬁcant amount of the
CCs were critical isthmuses for VT (8).
In the present study, our goal was to investigate
whether the CC identiﬁed by LGE-CMR could be
used to predict risk for patients with systolic HF.
METHODS
Patient populations. This is a retrospective cohort
study of an LGE-CMR database from 2004 to 2011.
Patients with known renal dysfunction or estimated
glomerular ﬁltration rate <30 ml/min/1.73 m2 were
excluded from the CMR examination according
to the American College of Radiology manual of
contrast media. We surveyed the LGE-CMR data-
base of the National Taiwan University Hospital
and selected patients with left ventricular ejection
fraction (LVEF) below 50% and with hyper-
enhancement on LGE-CMR. A total of 130
patients with LVEF <50% had a LGE-CMR ex-
amination. All patients had clinical symptoms and
signs of congestive HF. We excluded 10 subjects
with previous acute myocardial infarction (MI)supported in part by the National Science Council, Taiwan (grant numbers: NS
authors have reported that they have no relationships relevant to the contents of
Manuscript received November 9, 2012; revised manuscript received May 3,whose LGE-CMR images were acquired within
3 months post-infarction. To investigate the prog-
nostic value of LGE-CMR image parameters, we
excluded 21 patients whose LV function deteriorated
or recovered dramatically during follow-up (LVEF
with over 15% of variation); the LVEF measured
by various image modalities (echocardiography or
radionuclide angiography) should have remained
stationary in subsequent visits even after interventions
such as percutaneous coronary intervention, coronary
artery bypass graft, valve replacement or repair sur-
gery, and cardiac-resynchronization therapy. Of the
remaining 99 subjects, only 63 subjects with available
LGE-CMR raw data were included for analyses.
The basic demographics; cardiovascular risk fac-
tors, including hypertension, diabetes mellitus,
dyslipidemia, and chronic kidney disease
(CKD), deﬁned as estimated glomerular
ﬁltration rate <60 ml/min, etiologies
of impaired HF; medications of the in-
cluded subjects; and other cardiovascular
disease, such as ischemic stroke or pe-
ripheral arterial occlusive disease, were
obtained by reviewing medical records.
The outcomes, including malignant ven-
tricular tachycardia and mortality etiol-
ogies, were also obtained by reviewing
medical records or the National Health
Institute database in Taiwan.
Magnetic resonance imaging. The study
was performed on a 1.5-T magnetic reso-
nance imaging system (Sonata, Siemens,
Erlangen, Germany) with a 4-channel
phased array torso coil. Cine CMR
was ﬁrst performed using a segmented
balanced steady-state free precession
gradient echo pulse sequence with a
retrospective electrocardiographic R-wave gating.
The scanning parameters were repetition time, 3.9
ms; echo time, 1.6 ms; ﬂip angle, 70; bandwidth,
977 Hz/pixel; slice thickness, 7 mm; gap, 3 mm;
matrix size, 256  159; and pixel size, 1.3 mm 
1.3 mm. Multiple short-axis slices were prescribed
from the mitral oriﬁce to the LV apex. A total of
approximately 10 to 12 short-axis slices were ob-
tained, depending on cardiac size. For each slice
level, patients were required to hold their breath for
approximately 10 s. The true temporal resolution
was 49 ms, and 30 cardiac phases were recon-
structed for each slice level.
VT = vC-99-2314-B-002-116-MY3 and NSC-102-2314-B-002-087-MY2). The
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1154The LGE-CMR image study was performed by
slow infusion of a gadolinium-based contrast agent
(Magnevist, Berlex Laboratories, Wayne, New Jersey)
through the left antecubital vein; the dose was 0.2
mmol/kg body weight. Ten minutes after contrast
medium injection, LGE images were acquired in the
same short-axis planes as those used for cine images
by using an electrocardiographic R-wave–triggered,
phase-sensitive inversion recovery (PSIR) prepared
segmented fast gradient echo pulse sequence (9). The
scanning parameters were inversion time (TI)/repeti-
tion time/echo time, 250 ms/9.6 ms/4.2 ms; ﬂip angle,
25; bandwidth, 130 Hz/pixel; slice thickness, 7 mm;
gap, 3 mm; matrix size, 256  192; and pixel size,
1.37 mm  1.37 mm. We acquired LGE-CMR
images using PSIR sequence with a ﬁxed TI of 250
ms. The PSIR sequence takes into account the polarity
of the z-magnetization, and so the contrast between
the normal myocardium and the scar is kept relatively
stable despite the mismatch of the TI with the null
point of the normal myocardium (10). This feature
allows us to complete the acquisition of the LGE-
CMR images quickly, without spending time on
adjusting the TI.
Image analysis. LV FUNCTION AND MASS ANALYSIS
FROM CINE CMR. Detailed procedures regarding
LV function and mass analysis have been described
elsewhere (11). Brieﬂy, the endocardial and epicar-
dial contours of the LV in the short-axis view were
determined at each slice level by a user-interface
graphics program, which used a gray-level auto-
contouring algorithm provided by MATLAB
version 7.9 (MathWorks, Natick, Massachusetts).
The area enclosed by each contour was computed.
The LV volumes for each time point were then
determined by Simpson’s rule to obtain the volume–
time curve of the LV. This is equivalent to the sumA B
Figure 1. Illustration of a CC
A conductive channel (CC) is considered if a corridor of the heterogeneou
a 1-end corridor (A), or 2 ends, a 2-end corridor (B), connecting to the no
the scar without penetration into the scar (C), it is not considered a CCof the areas of the corresponding slice levels multi-
plied by the slice thickness plus gap. The end-
diastolic volume and end-systolic volume were
assessed from the maximal and minimal values of the
volume–time curve. These values were used to
compute the LVEF. LV mass was computed as the
difference between LV epicardial volume at end-
diastole and end-diastolic volume, multiplied by
the density of the myocardium, which is 1.05 g/ml.
QUANTIFICATION OF THE CORE SCAR AND GRAY
ZONE. The infarct and remote zones were deter-
mined on LGE-CMR images for each patient. On
the LGE images, the endocardial and epicardial
contours were manually traced to deﬁne the LV wall.
The infarct zone was deﬁned as the sector of the LV
wall that contained hyperenhancement of any trans-
murality. The remote zone was deﬁned as the
remaining portion of the LV wall that did not
contain hyperenhancement. In the infarct zone, a
pixel was counted as the core scar if its signal in-
tensity (SI) was higher than 3 SD above the average
SI of the remote myocardium, and it was counted as
the gray zone if the SI was between 2 and 3 SD
above the average SI of the remote zone (12). The
volumes of the core scar and of the gray zone were
quantiﬁed based on the Simpson’s rule: volume ¼
(summation of the interested areas of all short-axis
slices)  (slice thickness þ gap). The volumes were
normalized by an individual’s total LV mass volume
and are expressed in terms of percentages.
IDENTIFICATION OF THE CONDUCTIVE CHANNELS.
The CC in the ventricular wall was identiﬁed and
deﬁned according to a previous study (8). Two in-
vestigators (L.Y.L. and M.Y.S.), who were blinded
to the outcomes, analyzed the data. A custom-
developed MATLAB program was used to create aC
s tissue (blue zone) penetrates the scar (yellow zone) with its 1 end,
rmal myocardium (red zone). If the gray zone (blue zone) surrounds
.
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1155computer-assisted image that was derived by sub-
tracting the difference of the areas between regions
with an SI over 2 SD and regions over 3 SD for each
short-axis slice. (8). As illustrated in Figure 1, by
visually reviewing each subtraction image, a CC is
considered if a corridor of the heterogeneous tissue
(blue zone) penetrates the scar (yellow zone) with its
1 end (Fig. 1A) or 2 ends (Fig. 1B) connecting to the
normal myocardium (red zone). If the gray zone
surrounds the scar without deep penetration into the
scar (Fig. 1C), it is not considered a CC. Figures 2A
and 2B are LGE-CMR images that were obtained
from 2 patients with a CC in the infarct zones.
Figure 2C shows images of a patient without a CC.
The presence of a CC was only accepted if both
investigators independently agreed on the outcome.
In this study, we used the phase image of the PSIR
as opposed to the magnitude image to quantify the
myocardial scar and CC. The beneﬁts of the
reconstructed image include reduction of sensitivity
in B1 ﬁeld inhomogeneity, increased tolerance of TI,
background noise reduction, and nearly complete
magnetization recovery (9).Figure 2. Computer-Assisted Visual Identiﬁcation of a CC in LGE-CM
The ﬁrst column (RAW) shows the late gadolinium enhancement–card
SD) shows the division of the left ventricular myocardium into the yellow
threshold in the remote myocardium. The red region has a SI lower tha
the threshold of the mean þ3 SD in the remote myocardium. The fou
yellow region has a SI > the mean þ3 SD, the red region has a SI < the
and the mean þ3 SD. A and B show LGE-CMR images with conductive
deﬁned as a corridor of the gray zone (blue zone) surrounded by theStatistics. The normality of the variables was tested
by the Shapiro-Wilk test. Continuous variables with
normal distribution are expressed as means  SD,
whereas those that were not normally distributed are
reported as medians and interquartile ranges (25%
to 75%). Categorical variables were expressed as
percentages. The demographics, etiology for HF,
medication usage, and image variables were com-
pared between patients with different outcomes by
using the Student t test for normally distributed
continuous variables and by using the Mann-
Whitney U test for those that were not normally
distributed. Categorical variables between patients
with different outcomes were compared by the
Fisher exact test. The predictors for outcomes,
which included VT, ventricular ﬁbrillation (VF),
and total mortality, were analyzed by a univariate
Cox regression model. The hazard ratio (HR) was
calculated for each LGE-CMR variable. The pres-
ence of CC was entered as a categorical variable (yes
or no). The LVEF, the LV mass, the core scar, and
the gray zone were also entered as categorical vari-
ables by using their median values as cut pointsR Images
iac magnetic resonance (LGE-CMR) images. The second column (>2
region, which has a signal intensity (SI) higher than the mean þ2 SD
n this threshold. The third column (>3 SD) shows the division using
rth column (Subtraction) shows 3 divisions of the myocardium; the
mean þ2 SD, and the blue region has a SI between the mean þ2 SD
channels (CCs) (arrows), and C shows images without CCs. A CC was
scar with its end(s) connecting to the normal myocardium.
Table 1. Basic Demo
Parameters in Subje
Age, yrs
Male
Risk factors
HTN
DM
Dyslipidemia
CKD
Comorbidities
Old MI
Other CVD
Etiologies for HF
Ischemic CMP
Dilated CMP
Valvular heart disea
Medications
Antiplatelet
Beta-blocker
ACEI/ARB
CMR parameters
LVEF, %
LV mass, g
LVEDV, cm3
Core scar
Gray zone
Patients with CC
Other outcomes durin
follow-up
New stable angina
New ACS
Follow-up, days
Values are mean  SD, %
ACEI/ARB ¼ angiotensin
nary syndrome; CC ¼ con
cardiovascular magnetic
failure; HTN ¼ hypertens
left ventricular ejection fr
tachycardia.
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1156($ or < median values). For Kaplan-Meier survival
analysis, patients were divided into 2 groups that
were stratiﬁed according to the existence of the CC.
Between-group differences in survival were tested
by log-rank statistics. A p value <0.05 was con-
sidered statistically signiﬁcant.
RESULTS
A total of 63 patients, age 27.3 to 83.3 years, were
included. Of this total, 14 patients were women andgraphics, Risk Proﬁle, Medication Use, and CMR Image
cts With and Without VT/VF
VT/VF
(n [ 8)
Free of VT/VF
(n [ 55) p Value
59.3  15.2 60.6  11.7 0.744
75.0 78.2 1.000
25.0 27.3 1.000
12.5 34.5 0.418
25.0 20.0 0.665
62.5 25.9 0.050
62.5 32.7 0.129
0.0 5.5 1.000
87.5 87.3 0.581
12.5 9.1 1.000
se 0.0 3.6 1.000
25.0 34.5 0.708
37.5 60.0 0.272
37.5 60.0 0.272
31.0 (25.3–33.8) 36.0 (26.0–44.0) 0.457
167.3  59.1 157.8  44.0 0.589
172.6 (114.8–222.3) 179.0 (148.7–250.5) 0.393
43.9  18.3 34.3  15.3 0.109
12.0  2.9 12.9  2.7 0.189
75.0 16.4 <0.001
g
12.5 9.1 0.573
0.0 3.6 1.000
137 (47–1,117) 1,508 (456–1,950) 0.016
, or median (interquartile range).
-converting enzyme inhibitor/angiotensin receptor blocker; ACS ¼ acute coro-
ductive channel; CKD ¼ chronic kidney disease; CMP ¼ cardiomyopathy; CMR ¼
resonance; CVD ¼ cardiovascular disease; DM ¼ diabetes mellitus; HF ¼ heart
ion; LV ¼ left ventricular; LVEDV ¼ left ventricular end-diastolic volume; LVEF ¼
action; MI ¼ myocardial infarction; VF ¼ ventricular ﬁbrillation; VT ¼ ventricular49 were men. The median number of follow-up days
was 1,379 (interquartile range, 271 to 1,896) days.
Three cases were lost during follow-up. During the
follow-up period, 8 patients had VT/VF attacks, and
14 patients died. Among the 14 mortalities, 6 patients
died of ventricular tachycardia, 4 died of congestiveHF,
2 died of severe sepsis, and 2 died of respiratory failure.
The basic demographics, risk factors, etiology for HF,
comorbidities, medication usage, CMR image param-
eters, and the incidence of new stable angina or
acute coronary syndrome (ACS) during follow-up
between patients with and without VT/VF are sum-
marized in Table 1. As shown in Table 1, patients with
VT/VF were more likely to have CKDwith borderline
signiﬁcance (62.5% vs. 25.9%, p¼ 0.050). Among the
LGE-CMR image parameters, only the probability of
identifying the CC by LGE-CMR was higher in pa-
tientswithVT/VF(75.0%vs. 16.4%,p< 0.001).Other
statistically insigniﬁcant variables between the 2 groups
included age, sex, incidence of hypertension, diabetes
mellitus, dyslipidemia, old MI, other cardiovascular
diseases, etiologies for HF, the percentage of anti-
platelet, beta-blocker, and angiotensin-converting
enzyme inhibitor/angiotensin receptor blocker usage,
LVEF, LV mass, the percentages of the core scar and
gray zone, and the incidence of new stable angina or
ACS during follow-up.
The basic demographics, risk factors, HF etiol-
ogy, comorbidities, medication usage, CMR vari-
ables, and the incidence of new stable angina or
ACS during follow-up between mortality and sur-
vival groups are summarized in Table 2. Among the
variables, the incidence of CKD (57.1 vs. 22.9,
p ¼ 0.022), old MI (64.3% vs. 28.6%, p ¼ 0.026),
and the probability of the identiﬁcation of the CC
(50.0% vs. 16.3%, p ¼ 0.004) were signiﬁcantly
higher in the mortality group. Other variables were
not statistically signiﬁcant between the mortality
and survival groups.
The HR of each CMR image variable in predicting
different outcomes is shown in Table 3. The median
values for LVEF, LV mass, core scar, and gray zone
are 37.5%, 148.5 g, 33.41%, and 12.9%, respectively.
Among the CMR image parameters, the identiﬁcation
of the CC was positively associated with VT/VF at-
tacks during follow-up (HR: 27.032, 95% conﬁdence
interval [CI]: 3.291 to 222.054, p ¼ 0.002). The
LVEF (HR: 0.119, 95% CI: 0.015 to 0.977, p ¼
0.048) was inversely associated with VT/VF attacks.
Other parameters, which included LV mass and per-
centages of the core scar and gray zone, were not
signiﬁcantly associated with VT/VF attacks. As for the
prediction of total mortality, the identiﬁcation of the
CC (HR: 4.766, 95% CI: 1.643 to 13.824, p¼ 0.004)
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1157and the LVEF (HR: 0.491, 95% CI: 0.261 to 0.925,
p ¼ 0.028) were also predictors for excess mortality.
Figure 3 shows the Kaplan-Meier survival curves
for VT/VF attacks (Fig. 3A) and total mortality
(Fig. 3B). Log-rank statistics showed that patients
with a CC had a signiﬁcantly poorer prognosis than
those without a CC (p < 0.001 and p ¼ 0.007 for
VT/VF and total mortality, respectively).Table 2. Basic Demographics, Risk Proﬁle, Medication Use, and CMR Image
Parameters in Subjects With and Without Mortality
Mortality
(n [ 14)
Survival
(n [ 49) p Values
Age, yrs 62.7  12.3 59.8  12.1 0.438
Male 64.3 81.6 0.272
Risk factors
HTN 35.7 24.5 0.498
DM 28.6 32.7 1.000
Dyslipidemia 21.4 20.4 1.000
CKD 57.1 22.9 0.022
Comorbidities
Old MI 64.3 28.6 0.026
Other CVD 0.0 6.1 1.000
Etiologies for HF
Ischemic CMP 100.0 87.8 0.182
Dilated CMP 0.0 10.2 0.323
Valvular heart disease 0.0 2.0 1.000
Medications
Antiplatelet 42.9 30.6 0.522
Beta-blocker 42.9 61.2 0.240
ACEI/ARB 35.7 63.3 0.124
CMR parameters
LVEF, % 31.4 (25.8–34.5) 36.0 (26.0–44.5) 0.679
LV mass, g 163.2  45.8 157.9  46.2 0.705
LVEDV, cm3 172.6 (144.3–215.5) 179.0 (147.0–257.1) 0.566
Core scar 41.7  18.0 33.7  15.0 0.100
Gray zone 14.4  4.0 10.7  2.8 0.574
Patients with CC 50.0 16.3 0.004
Other outcomes during
follow-up
New stable angina 10.2 7.1 1.000
New ACS 7.1 2.0 0.398
Follow-up, days 81 (46–407) 1,542 (650–1,986) <0.001
Values are mean  SD, %, or median (interquartile range).
Abbreviations as in Table 1.DISCUSS ION
Our results showed that among the LGE-CMR
image parameters, only the presence of the CC
and lower LVEF were signiﬁcantly associated with
VT/VF attacks and total mortality.
LGE-CMR has emerged as an important clinical
tool in predicting cardiac events in patients with
HF (5,6,12–18). Many studies have demonstrated that
the extension of the scar measured by LGE-CMR is
superior to traditional risk predictors such as LVEF
and LV volumes in predicting future cardiac events
(13–17). In the present study, we showed that the
percentages of the core scar and gray zone are not
associated with VT/VF attacks and total mortality. It is
likely that the “quality” of the scar, such as tissue het-
erogeneity or presence of the CC, rather than the
quantity plays a larger role in the generation of VT/VF.
Many previous reports have shown the impor-
tance of the scar heterogeneity, that is, the peri-scar
gray zone in predicting cardiac events. These reports
suggest that the residual peri-infarct myocardium
might provide the substrate for arrhythmias and/or
ischemia (5,6,12,14,18). In contrast to these previ-
ous studies, our data showed that the percentage of
the gray zone is not a predictor for either VT/VF
and total mortality. One possible explanation is that
the criteria of SI to identify the core scar and the
gray zone are different among studies. Another
possibility is that the patients in the current analysis
seldom (3.2% had new stable angina, and 9.5% had
ACS) had any new ischemic episodes during follow-
up. It is well known that revascularization of the
ischemic regions could substantially reduce the
incidence of ventricular arrhythmia in patients with
ischemic cardiomyopathy (19,20). It is possible that
a peri-infarct gray zone without ischemia is elec-
trophysiologically more stable and is less likely
to generate VT/VF. Finally, the critical site of VT/
VF generation has been shown to be located pre-
dominately within the region of the core scar (8,21).
This explains our main ﬁnding that the presence of
the CCwithin the core scar is better than quantifying
scar heterogeneity in predicting VT/VF attacks.Human studies have shown that the slow con-
duction area or critical isthmus of the scar-related
VT re-entrant circuit is composed of bundles of
viable, but injured, myocytes embedded in the scar
tissue (22,23). The heterogeneous tissue, although
mainly located in the peri-scar region, is most
likely more harmful when located within the core
scar area, resulting in the formation of the so-called
CC. The CC can now be identiﬁed invasively by
endocardial voltage mapping and has become a
standard procedure for scar-related VT ablation
(24,25). In a recent cross-sectional design study,
Perez-David et al. (8) showed that the CC could
be identiﬁed noninvasively by computer-assisted
Table 3. Hazard Ratios and 95% CIs of the Univariate Cox
Regression Model With VT/VF Attacks and Mortality as
Outcome
VT/VF
(n [ 8)
Total Mortality
(n [ 14)
LVEF 0.119 (0.015–0.977)
p ¼ 0.048
0.491 (0.261–0.925)
p ¼ 0.028
LV mass 1.657 (0.396–6.941)
p ¼ 0.489
0.918 (0.515–1.637)
p ¼ 0.771
Core scar 3.751 (0.753–18.677)
p ¼ 0.106
1.134 (0.628–2.047)
p ¼ 0.677
Gray zone 0.251 (0.050–1.249)
p ¼ 0.091
0.615 (0.337–1.122)
p ¼ 0.113
Presence of CC 27.032 (3.291–222.054)
p ¼ 0.002
4.766 (1.643–13.824)
p ¼ 0.004
Abbreviations as in Table 1.
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1158visual identiﬁcation of the LGE-CMR image. By
concomitant EAVM and electrophysiology study,
the authors also showed that each CC identiﬁed by
noninvasive method corresponded to a similar
channel detected by EAVM, and a majority of the
channels were related to VT critical isthmuses (8).
In the present study, we further demonstrated
that CC could also help identify patients at risk
of VT/VF. Furthermore, in the present study, 6 of
14 patients died of VT/VF; therefore, the CC
also became a predictor for total mortality.
Study limitations. First, the study population is
small, and the study cohort is retrospective. Second,
because we did not perform EAVM for our pa-
tients, there were no invasive data to validate
the CC identiﬁed by LGE-CMR. Third, in this
study, all of the LGE images were acquired
with an inversion recovery prepared segmentedA
Figure 3. Kaplan-Meier Survival Curves and Log-Rank Statistics for
Statistics for ventricular tachycardia (VT)/ventricular ﬁbrillation (VF) attack
with conductive channels, whereas the blue lines represent patients w2-dimensional (2D) turbo fast low angle shot
sequence, not the 3-dimensional sequence. The
LGE images acquired with the 2D sequence only
allows us to identify corridors within each 2D im-
age. We cannot perform 3-dimensional recon-
struction of the LGE images and examine the
vertical corridors as Perez-David et al. (8) did.
Also, each LGE-CMR slice image was 3 mm apart,
which may not be close enough to detect any po-
tential CC located between the slices. However, the
slices were uniformly distributed, and the coverage
reached up to 70% of the whole LV myocardium.
The impact of underestimating CC or scar should
be insigniﬁcant. Despite this limitation, our results
show that the conductive channels identiﬁed on
2D images still constitutes a good predictor of
ventricular tachycardia in patients with HF. Finally,
the identiﬁcation of the CC is sensitive to the
deﬁnition of the SI thresholds of core scar and gray
zone. The main reason for using a 3 SD threshold
to identify the infarct zone is because the area
produced by this threshold matches closely with
what is shown on the LGE images by visual in-
spection. The optimal deﬁnition should be vali-
dated by invasive 3-dimensional EAVM.CONCLUS IONS
We demonstrated that a CC identiﬁed in an LGE-
CMR image can help identify patients at risk of
VT/VF. Large-scale studies are needed to conﬁrm
whether this ﬁnding could guide the physicians to
choose proper therapy (for example, an implantableB
VT/VF Attacks and Mortality
s (A) and mortality (B) are shown. The green lines represent patients
ithout conductive channels.
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1159cardioverter-deﬁbrillator) for their patients with
HF.
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